SCD, a global leader in defense technology specializing in the development and manufacture of a wide range of cooled and uncooled infrared detectors and high-power laser diodes, announces significant ...
Chronic pain is the most common complication affecting adults with sickle cell disease (SCD). 1 Pain profoundly affects people’s quality of life, functional ability, and health care utilization.
SCD is often promoted for people with inflammatory bowel diseases (IBD), but very few studies support its effectiveness. Over the last decade, the incidence of IBD has increased worldwide. Symptoms ...
SAN ANTONIO, Texas and DENVER, Colorado, June 11, 2025 (GLOBE NEWSWIRE) -- The Autonomous Reanimation and Evacuation (AREVA) Research Institute and SeaStar Medical (Nasdaq: ICU) announced today that a ...
Pfizer’s sickle cell disease (SCD) drug has flunked a key phase 3 test, the latest blow to the pharma’s $5.4 billion acquisition of Global Blood Therapeutics. Pfizer acquired the P-selectin inhibitor, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback